EP Patent

EP3897570A1 — Pharmaceutical composition comprising glp-1 analogue

Assigned to KRKA dd · Expires 2021-10-27 · 5y expired

What this patent protects

The present invention discloses new pharmaceutical compositions containing a Glucagon-like peptide-1 (GLP-1) analogue optionally in a combination with one or more other active substances. The present invention further provides methods for making the same.

USPTO Abstract

The present invention discloses new pharmaceutical compositions containing a Glucagon-like peptide-1 (GLP-1) analogue optionally in a combination with one or more other active substances. The present invention further provides methods for making the same.

Drugs covered by this patent

Patent Metadata

Patent number
EP3897570A1
Jurisdiction
EP
Classification
—
Expires
2021-10-27
Drug substance claim
No
Drug product claim
No
Assignee
KRKA dd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.